Pre-Open Stock Movers 05/10: Biohaven Surges on Takeover; Upstart, GoodRx Slashed on Outlook (more...)

Pre-Open Stock Movers:

Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE: PFE ) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.

Upstart Holdings (NASDAQ: UPST ) 57% LOWER; reported Q1 EPS of $0.61, $0.07 better than the analyst estimate of $0.54. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.25 million. Upstart Holdings sees Q2 2022 revenue of $295-305 million, versus the consensus of $335 million.

Vroom (VRM) 53% HIGHER; reported Q1 EPS of ($0.71), $0.30 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $923.78 million versus the consensus estimate of $874.09 million.

GoodRx Holdings, Inc. (GDRX) 31% LOWER; reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $203.3 million versus the consensus estimate of $200.2 million. GoodRx Holdings, Inc. sees Q2 2022 revenue of $190 million, versus the consensus of $215.6 million.

Novavax (NASDAQ: NVAX ) 25% LOWER; reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million. Novavax sees FY2022 revenue of $4-5 billion.

Duke Realty Corporation (NYSE: DRE ) 19% HIGHER; Prologis , Inc. (NYSE: PLD ), the global leader in logistics real estate, today sent a letter to James B. Connor, Chairman and Chief Executive Officer of Duke Realty Corporation (DRE) proposing to acquire Duke Realty in an all-stock transaction.

Peloton (NASDAQ: PTON ) 17% LOWER; reported Q3 EPS of ($2.27), $1.42 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $964.3 million versus the consensus estimate of $972.88 million. Peloton sees Q4 2022 revenue of $675-700 million, versus the consensus of $821.7 million.

Shockwave Medical (NASDAQ: SWAV ) 16% HIGHER; reported Q1 EPS of $0.41, $0.23 better than the analyst estimate of $0.18. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $86.41 million. Shockwave Medical sees Q2 2022 revenue of $435-455 million, versus the consensus of $417.9 million.

Clover (JO: CLRJ ) Health Investments (CLOV) 14% HIGHER; reported revenue for the first quarter of $874.4 million versus the consensus estimate of $787.4 million. Clover Health Investments sees FY2022 revenue of $3-3.4 billion, versus the consensus of $3.24 billion.

Groupon (NASDAQ: GRPN ) 12% LOWER; reported Q1 EPS of ($0.80), $0.28 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $153.3 million versus the consensus estimate of $165.81 million. Groupon sees Q2 2022 revenue of $155-165 million, versus the consensus of $202.4 million. Groupon sees FY2022 revenue of $670-700 million, versus the consensus of $837.08 million.

Hims & Hers Health, Inc. (HIMS) 7% HIGHER; reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $101.3 million versus the consensus estimate of $91.17 million. Hims & Hers Health, Inc. sees FY2022 revenue of $103-106 million, versus the consensus of $92.45 million. Hims & Hers Health, Inc. sees FY2022 revenue of $410-425 million, versus the consensus of $377.85 million.

RingCentral, Inc. (NYSE: RNG ) 7% LOWER; reported Q1 EPS of $0.39, $0.05 better than the analyst estimate of $0.34. Revenue for the quarter came in at $468 million versus the consensus estimate of $458.67 million. RingCentral, Inc. sees Q2 2022 EPS of $0.40-$0.41, versus the consensus of $0.38. RingCentral, Inc. sees Q2 2022 revenue of $475.5-479.5 million, versus the consensus of $477.2 million. RingCentral, Inc. sees FY2022 EPS of $1.83-$1.87, versus the consensus of $1.71. RingCentral, Inc. sees FY2022 revenue of $1.99-2.015 billion, versus the consensus of $2.01 billion.

XPO Logistics (NYSE: XPO ) 6% HIGHER; reported Q1 EPS of $1.25, $0.32 better than the analyst estimate of $0.93. Revenue for the quarter came in at $3.47 billion versus the consensus estimate of $3.22 billion. XPO Logistics sees FY2022 EPS of $5.20-$5.60, versus the consensus of $5.19.

Rover Group (ROVR) 5% HIGHER; reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $28 million versus the consensus estimate of $26.54 million. Rover Group sees Q2 2022 revenue of $41-43 million, versus the consensus of $41.2 million. Rover Group sees FY2022 revenue of $160-180 million, versus the consensus of $174.07 million.

Autoliv (NYSE: ALV ), Inc. (ALV) 5% HIGHER; UBS upgraded from Neutral to Buy with a price target of $90.00 (from $103.00).

AMC Entertainment (NYSE: AMC ) 5% HIGHER; reported Q1 EPS of ($0.52), $0.11 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $785.7 million versus the consensus estimate of $736.23 million.

Microchip Technology (NASDAQ: MCHP ) 4% HIGHER; reported Q4 EPS of $1.35, $0.10 better than the analyst estimate of $1.25. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.82 billion. Microchip Technology sees Q1 2023 EPS of $1.32-$1.36, versus the consensus of $1.28. Microchip Technology sees Q1 2023 revenue of $1.918-1.992 billion, versus the consensus of $1.86 billion.

Uber (NYSE: UBER ) 4% HIGHER; CEO bought 200,000 shares

Blink Charging (BLNK) 3% HIGHER; reported Q1 EPS of ($0.36), $0.05 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.87 million.

Tiga Acquisition Corp. (TINV) 2% HIGHER; LGBTQ+ dating app Grindr will come public in a merger with the SPAC.